New research uncovers a direct molecular link between HIV and Alzheimer’s disease. A study shows HIV’s replication machinery competes with brain cell processes, actively accelerating the production of neurotoxins linked to Alzheimer’s. This discovery redefines our understanding of cognitive decline in people living with HIV.

In Singapore, 54% of daters value discussing sex, but only 23% do. This guide explores cultural norms and provides practical scripts for discussing sexual health, STDs, and the importance of regular testing to ensure your dating app experience is both safe and respectful.

A new modelling study analyses Doxy-PEP for syphilis prevention in Singapore. It reveals a stark choice between a broad approach averting more cases inefficiently, and a targeted strategy that is vastly more efficient. This analysis guides a responsible path forward, balancing prevention with the risks of antibiotic resistance.

Modern treatments allow people with HIV to live longer lives. This guide explores the health challenges of aging with HIV, such as chronic inflammation, and outlines proactive strategies in nutrition, exercise, and medical care to support long-term health.

This guide breaks down all the options for affordable STD testing in Singapore. Learn the most cost-effective way to get a comprehensive screen through public clinics, find anonymous HIV testing with NGOs, and understand when a private clinic might be the right choice for your needs.

We chronicle the 80-year battle against gonorrhoea, from the miracle of penicillin to the rise of a “superbug” resistant to nearly every antibiotic. Discover how this common STD evolved to defeat our best drugs and what the future of treatment and prevention looks like.

A new gonorrhoea vaccine programme in the UK uses a meningitis B vaccine (Bexsero) that offers 30-40% cross-protection. With rising antibiotic resistance, this is a major step in sexual health. While not a national programme in Singapore, the vaccine is available and research supports its use.

A new once-monthly oral PrEP pill, MK-8527, is entering final-stage trials after promising mid-stage results showed it was safe and well-tolerated. This major step forward could soon offer a more convenient and accessible alternative to daily pills and injections, significantly advancing global HIV prevention efforts.